Assay of moguisteine metabolites in human plasma and urine: conventional and chiral high-performance liquid chromatographic methods.
Moguisteine is a novel peripheral non-narcotic antitussive agent. Pharmacokinetic studies in animal and in man showed that no unchanged drug is present in plasma, urine and faeces after oral administration. The main active metabolite, M1, is the free carboxylic acid of moguisteine, which maintains a stereogenic centre and consists of R(+)-M1 and S(-)-M1 enantiomers. M1 is partly metabolized to M2, its sulfoxidation derivative. A conventional HPLC method is described for the simultaneous determination of M1 and M2 in human plasma and urine after administration of therapeutic moguisteine doses. Plasma samples, previously acidified with phosphoric acid, are extracted with dichloromethane; urine samples are analyzed after appropriate dilution with methanol. Chromatography is performed using a Lichrosorb RP2 column and a linear gradient. M1 enantiomers can be determined in plasma extracts and urine samples by a chiral HPLC method using a beta-cyclodextrin column. The analytical characteristics of both HPLC procedures proved to be adequate to analyze samples of subjects treated with therapeutic doses of moguisteine during clinical pharmacokinetic studies.
Castoldi
D
D
Boehringer Mannheim Italia S.p.A., Monza.
Oggioni
A
A
Renoldi
M I
MI
Ratti
E
E
Di Giovine
S
S
Bernareggi
A
A
D000996:Antitussive Agents / Q000097:blood* / Q000652:urine*; D002851:Chromatography, High Pressure Liquid / Q000379:methods* / Q000706:statistics & numerical data; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008752:Methylene Chloride; D010756:Phosphoric Acids; D012680:Sensitivity and Specificity; D013237:Stereoisomerism; D013844:Thiazoles / Q000097:blood* / Q000493:pharmacokinetics / Q000652:urine*; D053778:Thiazolidines
D000996:Antitussive Agents; D010756:Phosphoric Acids; D013844:Thiazoles; D053778:Thiazolidines; D008752:Methylene Chloride; C087933:moguisteine; C030242:phosphoric acid